Skip to main content
  • The DNA Technology Regulation Bill is under consideration

    Union Minister of State (Independent Charge) Science and Technology; Minister of State (Independent Charge) Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh said that , the Ministry of Home Affairs (MHA), has approved projects for strengthening DNA analysis, cyber-forensics and related facilities in 23 States/UTs under Nirbhaya Fund Scheme.

  • Indian scientific patents doubled in last three years

    The three departments functioning under the Ministry of Science and Technology - Department of Science and Technology (DST), Department of Biotechnology (DBT) and Department of Scientific and Industrial Research (DSIR) represent different areas of scientific research. These three departments have supported scientific research works, research publications, technology development; and has acquired significant scientific knowledge through innovations that contribute to the overall development of the country.

  • Pharmacy Council of India gets youngest president

    In election of pharmacy council of India, Dr. Montu Patel is elected as president of PCI. Dr. Montu Patel is became the youngest president of PCI.

    In Oct 2021, Dr. Montukumar Patel who is also president of Gujarat State Pharmacy council, has won the election of executive member in PCI. Dr. Montukumar Patel was elected unopposed as executive member. He was also became youngest president of Gujarat State Pharmacy Council few years back.

  • WHO establishes the Global Centre for Traditional Medicine in India

    The World Health Organization (WHO) and the Government of India today signed an agreement to establish the WHO Global Centre for Traditional Medicine. This global knowledge centre for traditional medicine, supported by an investment of USD 250 million from the Government of India, aims to harness the potential of traditional medicine from across the world through modern science and technology to improve the health of people and the planet.

  • New tech to aid screening and monitoring of lung diseases

    India has a high burden of Tuberculosis, recording close to 2.64 million cases and 75,000 plus deaths in 2019. A considerable percentage of these cases come from underdeveloped, remote areas without proper access to healthcare services. It is a huge challenge to triage, screen, and monitor it promptly, and at scale, with minimal resources.

  • Draft National Medical Devices Policy 2022 opens for feedback from stakeholders

    The Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers has released on its website, an Approach Paper for the Draft National Policy for the Medical Devices, 2022, inviting feedback and remarks of the Industry and stakeholders, till the 25th of March 2022.  In line with the mandate of promoting aspects of the medical device industry, the Department of Pharmaceuticals, realising the need to have a holistic policy to accelerate growth and explore the potential of the Medical Devices Sector, has published thiz approach paper, after extensive st

  • PCI mandate exit exam after diploma in pharmacy

    Pharmacy Council of India has mandated exit exam for D.Pharm candidates to register as pharmacist under section 12 of the Pharmacy Act, 1948. No person shall be registered as a Diploma in Pharmacy Exit Examination candidate unless he has passed Diploma in Pharmacy course from an institution approved by the PCI.

  • Government issues notification on stockpiling of new drug under phase 3 of clinical trial

    Government eases the norms of manufacturing, stocking, sale or distribution of new drugs under phase III clinical trials, for the treatment of Covid-19 and related diseases. The provision is made to stock the drugs with a condition that it will sell the new drug only after obtaining permission as per the regulations.

  • CSIR-CDRI Nucleic Acid Staining Dye technology licensed

    Lucknow based national laboratory CSIR-Central Drug Research Institute (CDRI), has licensed the technology of Nucleic Acid Staining Dye GreenR to GenetoProtein Pvt. Ltd., a start-up company registered in Uttar Pradesh in the year 2020. This startup is involved in developing an array of enzymes, kits and biochemical used in Lifesciences research, particularly molecular biology. The dye GreenR™ has been developed by CDRI Senior Principal Scientist Dr. Atul Goel in a joint collaborative project with an industry partner Biotech Desk Pvt. Ltd., Hyderabad.

  • Fluorescence technology to detect new corona virus discovered

    A team of scientists has developed a new technology, platform for fluorometric detection of pathogens such as viruses by measurement of fluorescent light emitted. The potential of the new technology has been demonstrated for the detection of SARS-CoV-2. This technology platform can also be used to detect other DNA/RNA pathogens such as HIV, influenza, HCV, Zika, Ebola, bacteria, and other mutating/evolving pathogens.

Subscribe to Government News

Search this website